冰岛 -
冰岛文 -
LYFJASTOFNUN (Icelandic Medicines Agency)
contalgin forðatafla 60 mg
mundipharma a/s - morphini sulfas - forðatafla - 60 mg
冰岛 -
冰岛文 -
LYFJASTOFNUN (Icelandic Medicines Agency)
contalgin forðatafla 5 mg
mundipharma a/s - morphini sulfas - forðatafla - 5 mg
冰岛 -
冰岛文 -
LYFJASTOFNUN (Icelandic Medicines Agency)
contalgin forðatafla 30 mg
mundipharma a/s - morphini sulfas - forðatafla - 30 mg
冰岛 -
冰岛文 -
LYFJASTOFNUN (Icelandic Medicines Agency)
contalgin forðatafla 200 mg
mundipharma a/s - morphini sulfas - forðatafla - 200 mg
冰岛 -
冰岛文 -
LYFJASTOFNUN (Icelandic Medicines Agency)
contalgin forðatafla 100 mg
mundipharma a/s - morphini sulfas - forðatafla - 100 mg
冰岛 -
冰岛文 -
LYFJASTOFNUN (Icelandic Medicines Agency)
contalgin forðatafla 10 mg
mundipharma a/s - morphini sulfas - forðatafla - 10 mg
欧盟 -
冰岛文 -
EMA (European Medicines Agency)
vpriv
takeda pharmaceuticals international ag ireland branch - velaglúserasa alfa - gauchersjúkdómur - Önnur meltingarvegi og efnaskipti vörur, - vpriv er ætlað til langtíma ensímuppbótarmeðferðar (ert) hjá sjúklingum með gaucher sjúkdóm af tegund 1.
欧盟 -
冰岛文 -
EMA (European Medicines Agency)
jorveza
dr. falk pharma gmbh - budesonide - Öndunarfærasjúkdómar - antidiarrheals, þarma bólgueyðandi / antiinfective lyfjum - jorveza er ætlað til meðferðar við eosinophilic esophagitis (eoe) hjá fullorðnum (eldri en 18 ára).
欧盟 -
冰岛文 -
EMA (European Medicines Agency)
opdualag
bristol-myers squibb pharma eeig - nivolumab, relatlimab - melanoma - antineoplastic agents, monoclonal antibodies - opdualag is indicated for the first line treatment of advanced (unresectable or metastatic) melanoma in adults and adolescents 12 years of age and older with tumour cell pd l1 expression < 1%.
冰岛 -
冰岛文 -
LYFJASTOFNUN (Icelandic Medicines Agency)
abstral tungurótartafla 800 míkróg
kyowa kirin holdings b.v. - fentanylum cítrat - tungurótartafla - 800 míkróg